Premium
Subcutaneous implantable pleural port catheter in the management of malignant pleural effusions in young patients with solid tumors: A new option in the armamentarium of symptomatic treatment
Author(s) -
Malterre Aline,
CohenGogo Sarah,
Kriegel Irène,
d'Avout Fourdinier Perrine,
Bouleuc Carole,
Lemelle Lauriane,
Surun Aurore,
Cordero Camille,
Pacquement Hélène,
Orbach Daniel
Publication year - 2021
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.29109
Subject(s) - medicine , malignant pleural effusion , pleural effusion , catheter , port (circuit theory) , palliative care , pleurodesis , subcutaneous port , mesothelioma , surgery , radiology , cancer , adenocarcinoma , pathology , electrical engineering , nursing , engineering , gastroesophageal junction
Abstract The contribution of subcutaneous implantable pleural port catheter (SIPP) for malignant pleural effusions (MPE) management in young patients with cancer, in a palliative care setting is not well explored. This monocentric series analyzed 38 patients, median age 18 years (range 3–25) with significant pleural effusion. SIPP were considered efficient for eight of 12 evaluable patients (67%) and allowed MPE outpatient management in five cases. SIPPs are safe and efficient device to manage MPE patients with solid tumors, in the palliative care setting. This original tool could help health care providers for thoracic symptom management in alternative to iterative pleural punctures.